These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension. Lacourcière Y. Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218 [Abstract] [Full Text] [Related]
11. Angiotensin II receptor blockers. A new class of antihypertensive drugs. Velasquez MT. Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326 [Abstract] [Full Text] [Related]
12. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?]. Waeber B, Nussberger J, Brunner H. Rev Prat; 1992 Oct 15; 42(16):2066-8. PubMed ID: 1485114 [No Abstract] [Full Text] [Related]
13. [Angiotensin II antagonists: a distinct therapeutic class]. Waeber B, Brunner HR. Presse Med; 1996 Oct 26; 25(32):1533-5. PubMed ID: 8952659 [Abstract] [Full Text] [Related]
14. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. Weber MA. J Hypertens Suppl; 1997 Dec 26; 15(6):S31-6. PubMed ID: 9493125 [Abstract] [Full Text] [Related]
15. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade? Brunner HR. J Hum Hypertens; 1995 Nov 26; 9(11):859-60. PubMed ID: 8583462 [No Abstract] [Full Text] [Related]